In 2017, Drs Jim Dowling, Hernan Gonorazky, Ronald Cohn and Craig Campbell jointly published an article called “Treating pediatric neuromuscular disorders: The future is now.”

Now, five years later, Muscular Dystrophy Canada has invited them for a panel discussion to speak about whether their predictions for the treatment of pediatric NMDs was right, what the current state of treatment for the most common pediatric neuromuscular conditions looks like and what are the treatment strategies with the greatest potential for helping children with neuromuscular disorders.

Speakers

Dr. James Dowling, Staff Clinician, Division of Neurology, The Hospital for Sick Children; Professor of Paediatrics and Molecular Genetics, the University of Toronto and Senior Scientist, Program of Genetics and Genome Biology, The Hospital for Sick Children

Dr. Hernan Gonorazky, Assistant Professor, Faculty of Medicine University of Toronto Division of Neurology, Department of Paediatrics and Director, Neuromuscular Fellowship Program, The Hospital for Sick Children

Dr. Ronald Cohn, President and CEO of the Hospital for Sick Children

Dr. Craig Campbell, Head of the Division of Pediatric Neurology and acting chair of the Department of Pediatrics and Professor of Pediatrics, Epidemiology and Clinical Neurological Sciences, Western University

Discussion Topics

1. The current state of treatment for the most common pediatric neuromuscular conditions

2. The treatment strategies with the greatest potential for helping with neuromuscular disorders

3. Whether their predictions at the time of publication (five years ago) were accurate, above or below expectations

4. The expected state of treatment for the most common pediatric neuromuscular conditions in five years

Watch the recording